Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Active, not recruiting | Phase 3 | 2026-07-06 | NCT04975737 | |
| The Surveillance Clinical Study of Rickettsiosis | Bacterial Infections and Mycoses, Infections, Rickettsiaceae infectious disease, Rickettsiosis, bacterial infectious disease, gram-negative bacterial infections, vector-borne disease | Recruiting | Not stated | 2026-02-19 | NCT06162975 | |
| Clinical Study of the Safety and Pharmacokinetics of the Drug Fluorothiazinone, a Concentrate for Solution Preparation for Infusion. | Safety and Pharmacokinetics | Not yet recruiting | Phase 1 | 2025-09-22 | NCT07184606 | |
| "Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients". | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Not yet recruiting | Phase 1 | 2025-09-05 | NCT07156864 | |
| Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-negative bacterial infections | Recruiting | Phase 2 | 2025-06-24 | NCT06135350 | |
| An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis" | Enterococcus faecalis infection, Klebsiella pneumonia | Not yet recruiting | Phase 3 | 2025-02-07 | NCT06815549 |